National
Democratic retirements could derail LGBT advances

U.S. Sen. Evan Bayh’s retirement could make it more difficult for congressional Democrats to advance LGBT-related bills. (Photo courtesy of Bayh’s office)
The surprise retirement announcement from Sen. Evan Bayh (D-Ind.) on Monday came as a political shock in Washington and fueled the notion that 2010 will be a bad year for Democrats.
While political experts are expecting Democrats to retain control of both the House and the Senate — albeit with slimmer majorities — pundits are saying pro-LGBT legislation would require an extra push from supporters following the election to make it through Congress.
Bayh formally announced Monday his intention to vacate his seat at the end of the year. Emphasizing his continued commitment to public service, Bayh said he wanted to retire in part because his desire to serve as a U.S. senator has waned.
“For some time, I’ve had the growing conviction that Congress is not operating as it should,” he said. “There is much too much partisanship and not enough progress, too much ideology and not enough practical problem solving.”
Bayh’s retirement came as a surprise to many because he was seen as a rising star in the Democratic Party and has been mentioned as a possible presidential candidate. The senator reportedly had $13 million in his coffers for a re-election campaign, and was the leader of a group of moderate Democrats that had pledged to work for centrist policies on Capitol Hill.
The Indiana senator hasn’t been at the forefront of LGBT causes during his tenure in Congress, but stepped up to the plate when support was necessary. Bayh voted against the Federal Marriage Amendment in 2004 and 2006, and voted in favor of hate crimes legislation.
Michael Mitchell, executive director of the National Stonewall Democrats, said Bayh’s record on LGBT issues is attributable to the fact that he comes from a state that’s somewhere between moderate and conservative in its political leanings.
“I think whoever takes his place is going to lean toward the more Blue Dog, or the more conservative side of the Democratic Party anyway,” Mitchell said. “It would be wonderful to see someone who’s pro-equality there, and we’ll see how that plays out.”
But Bayh’s retirement means an incumbent Democrat won’t be running for the seat, increasing the chances that a Republican could win the spot in November.
That’s why Sean Theriault, a gay government professor at the University of Texas, Austin, called Bayh’s decision to leave the Senate “bad news for the Democrats.”
“It takes a race that could have gone either way to a seat that the Democrats will most likely lose,” Theriault said. “More than that, though, the Senate is losing a good senator. Bayh was a legislator’s legislator. He knew how to work both sides of the aisle to get good legislation passed.”
Bayh’s retirement isn’t the only factor jeopardizing the Democratic majority in Congress this fall. Public dissatisfaction with Congress has many pundits predicting Republican wins.
In addition to the general climate turning against Democrats, issues in individual races could make for a challenging year for the party. The announced retirement of Sen. Byron Dorgan (D-N.D.) leaves little hope for a win against Republican Gov. John Hoeven in the Senate race this November. In Delaware, Republican congressman Mike Castle is favored to capture the Senate seat once held by Vice President Joseph Biden.
And in Illinois, the Democratic nominee for the U.S. Senate seat, Alexi Giannoulias, is being dogged by his association with Broadway Bank, which reportedly engaged in questionable practices and is on the verge of Federal Deposit Insurance Corp. takeover.
Even Senate Majority Leader Harry Reid (D-Nev.) is facing low approval ratings in his home state, making him vulnerable to a Republican challenger.
Still, while political experts are predicting Democrats will lose seats, most are saying the Republicans won’t be able to take the majority in either the House or Senate. Theriault said before the announcement of Bayh’s retirement, he would have thought the Democrats would hold 54 seats after the election.
“Now, it might be down to 53,” he said, “At every turn, the Republican primary electorate is going to have to make the right decision, catch some breaks, and conditions would have to deteriorate even more than they have for the Republicans to have a shot at gaining control of the Senate.”
Dan Pinello, a gay government professor at the City University of New York, said the growing number of Democratic incumbents who are announcing their retirement means Republicans will see more opportunities, but determining whether the Republicans will take control of Congress is difficult because other factors could emerge to influence the election.
“Both domestic as well as international events can happen at such lightning speed to change the larger political environment that the outlook can vary from month to month in terms of what’s going to be happening come November,” he said. “It’s very dicey to make predictions so far ahead of the general election.”
Still, Pinello said predicting Democrats will lose seats in Congress is a “safe” bet to make, although a GOP takeover would take “a seismic change” similar to what happened in 1994 when Democrats lost control of both chambers of Congress.
Charles Moran, spokesperson for the Log Cabin Republicans, said he doesn’t think Republicans will take control of Congress this November, although he predicted Democratic losses because the party will have to spend money on races that it thought wouldn’t be competitive.
“It’s going to give the Republicans a competitive advantage in terms of reclaiming some of these seats,” he said. “I’m certainly not sugar-coating it. We have a really big hole to fill on the Republican side, but I definitely think this puts the Democrats in a precarious position.”
With decreased majorities in Congress, advocates are saying pushing pro-LGBT legislation through to the president’s desk would be a more difficult feat.
Pinello said if the Democratic majority falls behind 55 seats in the Senate, it could cause a problem when seeking 60 votes to end any filibusters on LGBT-related legislation.
“That becomes a problem if ‘Don’t Ask, Don’t Tell’ comes up for repeal or, more importantly, the Defense of Marriage Act comes up for repeal,” he said. “I think potentially that becomes an insurmountable hurdle if Republicans remain as cohesive as they have been on the health care issue.”
Even with decreased majorities, Mitchell said advocates will “keep working” with Democratic allies to push through pro-LGBT legislation.
“Our organization worked specifically for the last 10 years as an organization working in the minority,” he said. “I think Obama will continue to help push some good legislation for us and do what he can, but that said, there needs to be a pro-equality Congress that can help us do that.”
Moran said while Democratic losses would mean the party would have to “re-evaluate some of their votes and some of their stances,” he would hope Democrats and Republicans who would vote for pro-LGBT legislation would maintain their support.
“More than anything, I think it’s just another example of how we’ve got to spend a lot of time as a community working to start changing some of the hearts and minds of the key individuals who maybe are sitting on the fence,” he said.
National
Rural LGBTQ youth face greater hurdles than urban peers: study
Online support is key for many young, queer Americans

A newly released report based on a nationwide U.S. survey of 1,267 LGBTQ young people from the age of 15 to 24 shows that LGBTQ youth living in rural communities face greater hurdles in coping with their sexual orientation or gender identity.
But the report, released by the youth advocacy organizations Hopelab and Born this Way Foundation, also shows that rural LGBTQ youth have benefited significantly by accessing online resources and support services.
The 20-page report, which was released on June 24, is entitled, “Exploring Pride and Support of LGBTQ+ Young People In Rural Communities.”
Here are the key findings of the research as stated in the report:
• Rural LGBTQ+ young people report that their schools (28% vs. 49%), communities (13% vs 35%), and households (47% vs 61%) are less supportive than those of their suburban/urban peers.
• Rural LGBTQ+ young people are significantly more likely than their suburban/urban peers to give (76% vs 70%) and receive (57% vs 51%) support through online friends and communities.
• Rural LGBTQ+ young people are significantly more likely than their suburban/urban peers to meet the threshold for depression (57% vs 45%) and report less flourishing than their suburban/urban counterparts (43% vs 52%).
• Rural LGBTQ+ young people who receive support from those they live with are more likely to be categorized as flourishing (50% vs 35%) and less likely to meet the cutoff for depression (52% vs 63%)than their counterparts with little or no support.
• Despite having less support for LGBTQ+ people in their in-person environments, rural young people report high LGBTQ+ pride at all levels comparable to their suburban/urban peers (85% vs 86%).
“The survey was developed through a collaborative process that included young people in every step, from co-designing survey methods to youth-centered co-distillation support in interpreting results,” a statement released by Hopelab and Born This Way Foundation says.
The statement adds, “The insights directly center on the perspectives of LGBTQ+ young people, ages 15-24, examining how they give and receive support online, their experiences with mental health and well-being, and ways they show kindness and offer support in the face of challenges.”
The report includes a quote from a survey interview of a participant it describes as a white, nonbinary young adult: “Being neurodivergent and Queer in a small town in the South means you’re not very likely to have friends. Finding these people online was my first gateway to being treated like a normal person by my peers. It has greatly shaped who I am today in a positive way. I think I’d still be terribly depressed had I never met them.”
The report concludes by pointing out that despite facing challenges, rural LGBTQ+ young people “demonstrate levels of pride and identity connection that are comparable to their suburban and urban peers.” It adds, “This suggests that even when direct support is lacking, many rural LGBTQ+ young people are still able to find avenues to connect to others similar to them and develop a sense of identity.”
The full report can be accessed at hopelab.org.
U.S. Supreme Court
Nine trans activists arrested outside Supreme Court
Gender Liberation Movement organized demonstration against Skrmetti ruling

On Friday afternoon, nine transgender organizers and allies were arrested on the steps of the U.S. Supreme Court for blocking the street and protesting the recent U.S. v. Skrmetti ruling.
The ruling, decided 6-3 by the conservative majority on Wednesday, upheld Tennessee’s ban on gender-affirming care for minors. The decision will allow states to pass laws restricting gender-affirming care for minors and further minimizes bodily autonomy.
The nine arrested were part of a larger group of more than 30 protesters wearing colors of the trans Pride flag— pink, blue, and white, — standing outside of the nation’s highest court. Organizers unfurled large cloths in pink, blue, and white, shared personal testimonies about how their gender-affirming care was a matter of life and death, released pink and blue smoke, and saw nine trans participants take their hormone replacement therapy.
The protest was led by the Gender Liberation Movement, an organization that “builds direct action, media, and policy interventions centering bodily autonomy, self-determination, the pursuit of fulfillment, and collectivism in the face of gender-based sociopolitical threats.” Among the nine arrested was GLM co-founder Raquel Willis.
Before being arrested, Willis spoke to multiple media outlets, explaining that this decision was an overreach of power by the Supreme Court.
“Gender-affirming care is sacred, powerful, and transformative. With this ruling in U.S. v. Skrmetti, we see just how ignorant the Supreme Court is of the experiences of trans youth and their affirming families,” said Willis. “Everyone deserves the right to holistic healthcare, and trans youth are no different. We will continue to fight for their bodily autonomy, dignity, and self-determination just like previous generations. No court, no law, no government gave us our power, and none can take it away.”
GLM co-founder Eliel Cruz also spoke to media outlets about the Skrmetti ruling, calling it “a historical moment of fascist attacks,” and encouraged the LGBTQ community to “organize and fight back.”
“As a cisgender man, I stand in solidarity with the trans community during these escalating attacks on their safety, well-being, right to exist in this world, and ability to live a future free of violence,” Cruz said. “I’m enraged at the Supreme Court’s decision to uphold a ban on gender-affirming care for youth. My heart hurts for the families and young people who this will negatively impact and harm.”
The Washington Blade reached out to Capitol Police for comment.
A spokesperson said the nine activists were arrested for violating D.C. Code §22-1307 — “Crowding, Obstructing, or Incommoding” — on First Street, N.E., after receiving three warnings.
National
FDA approves new twice-yearly HIV prevention drug
Experts say success could inhibit development of HIV vaccine

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months.
The new drug, lenacapavir, which is being sold under the brand name of Yeztugo by the pharmaceutical company Gilead Sciences that developed it, is being hailed by some AIDS activists as a major advancement in the years-long effort to end the HIV/AIDS epidemic in the U.S. and worldwide.
Although HIV prevention drugs, known as pre-exposure prophylaxis medication or PrEP, have been available since 2012, they initially required taking one or more daily pills. More recently, another injectable PrEP drug was developed that required being administered once every two months.
Experts familiar with the PrEP programs noted that while earlier drugs were highly effective in preventing HIV infection – most were 99 percent effective – they could not be effective if those at risk for HIV who were on the drugs did not adhere to taking their daily pills or injections every two months. Experts also point out that large numbers of people at risk for HIV, especially members of minority communities, are not on PrEP and efforts to reach out to them should be expanded.
“Today marks a monumental advance in HIV prevention,” said Carl Schmid, executive director of the D.C.-based HIV + Hepatitis Policy Institute, in a statement released on the day the FDA announced its approval of lenacapavir.
“Congratulations to the many researchers who spent 19 years to get to today’s approval, backed up by the long-term investment needed to get the drug to market,” he said.
Schmid added, “Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections – if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.”
Schmid and others monitoring the nation’s HIV/AIDS programs have warned that proposed large scale cuts in the budget for the U.S. Centers for Disease Control and Prevention by the administration of President Donald Trump could seriously harm HIV prevention programs, including PrEP-related efforts.
“Dismantling these programs means that there will be a weakened public health infrastructure and much less HIV testing, which is needed before a person can take PrEP,” Schmid said in his statement.
“Private insurers and employers must also immediately cover Yeztugo as a required preventive service, which means that PrEP users should not face any cost-sharing or utilization management barriers,” he said.
In response to a request by the Washington Blade for comment, a spokesperson for Gilead Sciences released a statement saying the annual list price per person using Yeztugo in the U.S. is $28,218. But the statement says the company is working to ensure that its HIV prevention medication is accessible to all who need it through broad coverage from health insurance companies and some of its own support programs.
“We’ve seen high insurance coverage for existing prevention options – for example, the vast majority of consumers have a $0 co-pay for Descovy for PrEP in the U.S. – and we are working to ensure broad coverage for lenacapavir [Yeztugo],” the statement says. It was referring to the earlier HIV prevention medication developed by Gilead Sciences, Descovy.
“Eligible insured people will get help with their copay,” the statement continues. “Gilead’s Advancing Access Copay Savings Program may reduce out-of-pocket costs to as little as zero dollars,” it says. “Then for people without insurance, lenacapavir may be available free of charge for those who are eligible, through Gilead’s Advancing Access Patient Assistance Program.”
Gilead Sciences has announced that in the two final trial tests for Yeztugo, which it describes as “the most intentionally inclusive HIV prevention clinical trial programs ever designed,” 99.9 percent of participants who received Yeztugo remained negative. Time magazine reports that among those who remained HIV negative at a rate of 100 percent were men who have sex with men.
Time also reports that some HIV/AIDS researchers believe the success of the HIV prevention drugs like Gilead’s Yeztugo could complicate the so-far unsuccessful efforts to develop an effective HIV vaccine.
To be able to test a potential vaccine two groups of test subjects must be used, one that receives the test vaccine and the other that receives a placebo with no drug in it.
With highly effective HIV prevention drugs now available, it could be ethically difficult to ask a test group to take a placebo and continue to be at risk for HIV, according to some researchers.
“This might take a bit of the wind out of the sails of vaccine research, because there is something so effective in preventing HIV infection,” Time quoted Dr. David Ho, a professor of microbiology, immunology, and medicine at New York’s Columbia University as saying.